Axinesis
PrivateLast Round
M&A
Mar 10, 2026
Total Funding Raised
$1.93M
Company Overview
Axinesis is a medical technology company that develops robotic devices for upper limb neurorehabilitation to assist patients with motor and cognitive disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Industrial Robotics, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axinesis Comparables
Compare Axinesis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tyromotion | 84% | |
| Bionik Laboratories Corp. | 81% | |
| DIH Medical | 80% | |
Axinesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Mar 10, 2026 |
Axinesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Université catholique de Louvain | VC Round |
| VIVES Partners | Seed |
| Nivelinvest | Seed |
| BioWin | Grant |
| Walloon Region (Belgium) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 77% MoM.
- May 3, 2025
Monthly visitors grew 1231% MoM, from 72 to 958.
Axinesis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Axinesis's valuation, stock price, and market status.